Eastman Chemical
751 hedge funds and large institutions have $9.92B invested in Eastman Chemical in 2024 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 283 increasing their positions, 249 reducing their positions, and 70 closing their positions.
114% more call options, than puts
Call options by funds: $48.3M | Put options by funds: $22.5M
19% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 70
14% more repeat investments, than reductions
Existing positions increased: 283 | Existing positions reduced: 249
1% more funds holding
Funds holding: 747 → 751 (+4)
0.52% more ownership
Funds ownership: 85.54% → 86.07% (+0.52%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2% less capital invested
Capital invested by funds: $10.1B → $9.92B (-$163M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$61.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$45.5M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$43.7M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$39.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$38.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Southpoint Capital Advisors
New York
|
-$80.2M |
| 2 |
JP Morgan Chase
New York
|
-$66.1M |
| 3 |
Millennium Management
New York
|
-$65M |
| 4 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$41.5M |
| 5 |
Morgan Stanley
New York
|
-$30.3M |
EMN Hedge Fund Activity: Q2 2024 in Review
751 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Eastman Chemical (EMN) for Q2 2024, worth a combined $9.92B — down 1.6% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new EMN positions and 70 closed out — a net gain of 13 holders — while 283 added to existing stakes and 249 trimmed.
The largest buyer was Truist Financial, adding an estimated $61.3M. The largest seller was Southpoint Capital Advisors, exiting entirely with an estimated $80.2M sold.
- 751 institutional investors held Eastman Chemical (EMN) as of Q2 2024, up from 747 in Q1 2024.
- Funds reported $9.92B of Eastman Chemical stock for Q2 2024, down 1.6% quarter-over-quarter.
- 83 funds opened new Eastman Chemical positions in Q2 2024 and 70 closed out, a net change of +13 holders.
- The largest Eastman Chemical buyer in Q2 2024 was Truist Financial, an estimated $61.3M added.
- The largest Eastman Chemical seller in Q2 2024 was Southpoint Capital Advisors, an estimated $80.2M sold.
Based on aggregated 13F filings for Q2 2024.